(Q35855131)

10 August 2017

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma (English)

1 reference

10 August 2017

1 reference

17

Stanley J Szefler

1 reference

10 August 2017

12

Robert F Lemanske

1 reference

10 August 2017

8

John V Fahy

1 reference

10 August 2017

16

Christine A Sorkness

1 reference

10 August 2017

3

Homer A Boushey

1 reference

10 August 2017

4

Vernon M Chinchilli

1 reference

10 August 2017

9

Monica Kraft

1 reference

10 August 2017

1

Aaron Deykin

1 reference

10 August 2017

10

Frank Leone

1 reference

10 August 2017

14

Gene R Pesola

1 reference

10 August 2017

2

Michael E Wechsler

1 reference

10 August 2017

5

Susan J Kunselman

1 reference

10 August 2017

7

Emily DiMango

1 reference

National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

10 August 2017

19

object named as

National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

1 reference

10 August 2017

Timothy J Craig

6

1 reference

10 August 2017

Stephen C Lazarus

11

1 reference

10 August 2017

Richard J Martin

13

1 reference

10 August 2017

Stephen P Peters

15

1 reference

10 August 2017

Elliot Israel

18

1 reference

10 August 2017

language of work or name

English

0 references

publication date

14 September 2006

1 reference

American Journal of Respiratory and Critical Care Medicine

10 August 2017

1 reference

10 August 2017

175

1 reference

10 August 2017

3

1 reference

10 August 2017

228-234

1 reference

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1899264

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1899264

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1899264

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1899264

Random-effects models for longitudinal data

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1899264

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

11 July 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Effects of montelukast and beclomethasone on airway function and asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Safety of long-acting beta-agonists--an urgent need to clear the air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Daily versus as-needed corticosteroids for mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Traditional and patient-centred outcomes with three classes of asthma medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200601-112OC

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

21 January 2018

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Measurement properties and interpretation of three shortened versions of the asthma control questionnaire

1 reference

12 December 2020

"Black box" warning: wake-up call or overreaction?

1 reference

12 December 2020

10.1164/RCCM.200601-112OC

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

16973987

1 reference